Development and reliability and validity test of the Fear of Cancer Scale (FOCS)
OBJECTIVE: To develop a Fear of Cancer Scale (FOCS) for non-cancer populations.
METHODS: FOCS was developed by classical measurement theory. A total of 15 college students were invited to conduct semi-structured interviews. Seven experts were invited for expert consultation. A total of 2012 Chinese college students who had completed the electronic questionnaire on WJX.cn platform was included. The reliability and validity of FOCS were verified. Multiple linear regression analysis was adopted to explore the influencing factors of cancer fear among college students and further verify the validity of FOCS.
RESULTS: There were 17 items in the FOCS, including two subscales - direct fear (8 items), and indirect fear (9 items). FOCS had good validity and reliability. Multiple linear regression showed that GAD-7 score, CSDS score, negative coping score, positive coping score, guardian's highest education, gender, life satisfaction, nationality and major were the influencing factors of cancer fear (p < .05).
CONCLUSIONS: The 17-item FOCS was a reliable and valid measure to examine the level of cancer fear in non-cancer populations.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:54 |
---|---|
Enthalten in: |
Annals of medicine - 54(2022), 1 vom: 06. Dez., Seite 2354-2362 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Feng, Lin-Sen [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anxiety |
---|
Anmerkungen: |
Date Completed 08.09.2022 Date Revised 07.10.2022 published: Print Citation Status MEDLINE |
---|
doi: |
10.1080/07853890.2022.2113914 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM34583206X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM34583206X | ||
003 | DE-627 | ||
005 | 20231226025955.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/07853890.2022.2113914 |2 doi | |
028 | 5 | 2 | |a pubmed24n1152.xml |
035 | |a (DE-627)NLM34583206X | ||
035 | |a (NLM)36066037 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Feng, Lin-Sen |e verfasserin |4 aut | |
245 | 1 | 0 | |a Development and reliability and validity test of the Fear of Cancer Scale (FOCS) |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.09.2022 | ||
500 | |a Date Revised 07.10.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVE: To develop a Fear of Cancer Scale (FOCS) for non-cancer populations | ||
520 | |a METHODS: FOCS was developed by classical measurement theory. A total of 15 college students were invited to conduct semi-structured interviews. Seven experts were invited for expert consultation. A total of 2012 Chinese college students who had completed the electronic questionnaire on WJX.cn platform was included. The reliability and validity of FOCS were verified. Multiple linear regression analysis was adopted to explore the influencing factors of cancer fear among college students and further verify the validity of FOCS | ||
520 | |a RESULTS: There were 17 items in the FOCS, including two subscales - direct fear (8 items), and indirect fear (9 items). FOCS had good validity and reliability. Multiple linear regression showed that GAD-7 score, CSDS score, negative coping score, positive coping score, guardian's highest education, gender, life satisfaction, nationality and major were the influencing factors of cancer fear (p < .05) | ||
520 | |a CONCLUSIONS: The 17-item FOCS was a reliable and valid measure to examine the level of cancer fear in non-cancer populations | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Fear of Cancer Scale | |
650 | 4 | |a anxiety | |
650 | 4 | |a coping style | |
650 | 4 | |a reliability | |
650 | 4 | |a validity | |
700 | 1 | |a Wu, Xiao-Qian |e verfasserin |4 aut | |
700 | 1 | |a Li, Qing-Li |e verfasserin |4 aut | |
700 | 1 | |a Yang, Qing |e verfasserin |4 aut | |
700 | 1 | |a Yin, Fu-Lin |e verfasserin |4 aut | |
700 | 1 | |a Wang, Qi-Yao |e verfasserin |4 aut | |
700 | 1 | |a Zhu, Yu-Lu |e verfasserin |4 aut | |
700 | 1 | |a Yan, Ruo-Yu |e verfasserin |4 aut | |
700 | 1 | |a Tu, Chang-Ling |e verfasserin |4 aut | |
700 | 1 | |a Yang, Li-Ying |e verfasserin |4 aut | |
700 | 1 | |a Zhong, Wen-Jue |e verfasserin |4 aut | |
700 | 1 | |a Dong, Zheng-Jiao |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Annals of medicine |d 1996 |g 54(2022), 1 vom: 06. Dez., Seite 2354-2362 |w (DE-627)NLM012634972 |x 1365-2060 |7 nnns |
773 | 1 | 8 | |g volume:54 |g year:2022 |g number:1 |g day:06 |g month:12 |g pages:2354-2362 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/07853890.2022.2113914 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 54 |j 2022 |e 1 |b 06 |c 12 |h 2354-2362 |